What follow-up tests do I need after Lymphoma treatment ends

Follow-Up Testing After Lymphoma Treatment

Great question—follow-up testing is an important part of your care after treatment ends. The specific tests you'll need depend on your lymphoma type, stage, and how you responded to treatment. Let me explain the general approach and what to discuss with your team.

General Follow-Up Strategy

According to NCCN Guidelines, follow-up care typically focuses on:

1. Detecting recurrence early (if cancer returns)
2. Monitoring for treatment side effects
3. Managing long-term health concerns

The frequency and type of testing usually decrease over time as you move further from treatment completion.

Common Follow-Up Tests

Physical Exams

Your oncologist will examine you regularly, checking for swollen lymph nodes or other signs of recurrence. These visits typically happen every 3 months initially, then less frequently over time.

Imaging Tests

• CT scans or PET/CT scans may be repeated at specific intervals to look for any new cancer deposits. According to NCCN Guidelines, these are often done at 3-6 months after treatment, then less frequently if results remain normal.
• PET scans use a radioactive tracer to detect cancer cells. As the NCCN Guidelines explain, cancer cells show up as bright spots, though not all bright spots are cancer—inflammation or infection can also appear bright.

Blood Tests

• Complete blood count (CBC) to check for anemia or other blood cell abnormalities
• Metabolic panel to monitor kidney and liver function (important since some lymphoma treatments can affect these organs)
• Lactate dehydrogenase (LDH) - a marker that can indicate lymphoma activity

Molecular Residual Disease (MRD) Testing

This is an emerging area. According to recent NCCN Guidelines (December 2024), ctDNA-MRD testing (which detects circulating tumor DNA in blood) is now included in guidelines for B-cell lymphomas. This blood test can detect remaining cancer cells much earlier than imaging—approximately 200 days (6-7 months) before PET/CT imaging would show recurrence. MRD testing may help guide whether additional treatment is needed.

Bone Marrow Tests

Depending on your specific lymphoma type and initial staging, bone marrow aspirate or biopsy may be repeated to confirm remission.

What Varies by Lymphoma Type

The NCCN Guidelines for different lymphoma types (Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL, etc.) have slightly different follow-up recommendations. For example:

• Indolent lymphomas (slow-growing) may have longer intervals between imaging
• Aggressive lymphomas (fast-growing like DLBCL) typically have more frequent early follow-up
• Some patients may need bone marrow testing; others may not

Important Questions to Ask Your Oncologist

1. What is my specific lymphoma type and stage? (This determines your follow-up plan)
2. What imaging schedule do you recommend for me? (How often and what type?)
3. Will I have MRD testing, and if so, how will results guide my care?
4. How long will I need regular follow-up testing? (Usually 5 years minimum, sometimes longer)
5. What symptoms should I report between visits? (Fever, night sweats, swollen nodes, fatigue)
6. Are there any long-term side effects I should watch for? (Some treatments can affect heart, lungs, or fertility)
7. When can we transition to less frequent monitoring?

Why This Matters

Early detection of recurrence—whether through imaging, blood tests, or MRD testing—can make a significant difference in treatment options. That's why your care team will likely recommend a structured follow-up plan rather than just "wait and see."

Resources for More Information

The Lymphoma Research Foundation (lymphoma.org) and National Cancer Institute (cancer.gov) have detailed information about follow-up care specific to your lymphoma type.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncologist will create a follow-up plan tailored to YOUR specific situation, considering your lymphoma type, stage, treatment received, and how you responded. Don't hesitate to ask for a written summary of your follow-up schedule.